查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1810910

2025年止血劑和組織密封膠全球市場報告

Hemostats And Tissue Sealants Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年止血劑和組織密封膠市場將強勁成長，到2029年將達到56.1億美元，複合年成長率為6.6%。預測期內的成長動力包括：門診手術中心止血劑使用量的增加、對生物相容性和合成封閉劑的需求不斷成長、外科創新和研發投資的不斷擴大、術中血液管理意識的增強以及醫療保健支出的不斷成長。預計在此期間的主要趨勢包括：合成聚合物技術的進步、基於藥物傳遞的封閉劑的創新、止血劑在微創手術中的應用、雙功能封閉劑和止血劑的進步，以及生物工程和生物相容性材料的發展。

預計外科手術數量的增加將推動止血劑和組織密封膠市場的擴張。外科手術是指外科醫師使用技術和器械進行的診斷、治療或切除病變組織或器官，或恢復身體功能的程序。此類手術數量的增加主要是由於慢性疾病的盛行率上升，這些疾病通常需要外科手術介入才能妥善管理、治療和預防併發症。止血劑和組織密封膠在這些手術中發揮關鍵作用，它們能夠有效控制出血和封閉組織，從而最大限度地減少併發症並改善手術效果。例如，2024年6月，總部位於美國的整形外科專業組織國際美容外科學會 (ISAPS) 報告稱，2023年全球外科手術數量成長了5.5%，達到1580多萬例，非外科手術數量超過1910萬例。這一趨勢證實，外科手術數量的增加正在推動對止血劑和組織密封膠的需求。

止血和組織密封膠市場的主要企業正在優先開發創新產品，例如即用型可吸收膠原蛋白墊片，以提高外科手術的有效性和效率。這些基於膠原蛋白的止血鉗採用生物活性、可吸收材料製成，無需準備，可立即用於有效的組織密封和止血。 2025 年 4 月，美國醫療保健公司百特國際在奧地利舉行的研討會上推出了其 Hemopatch Seal 止血鉗。這款新產品設計用於室溫儲存，無需預熱，可隨時使用。它適用於開放性手術手術和微創手術，無需冷藏或額外準備。 Hemopatch 的強烈黏合強度、延長的保存期限和快速的止血反應使手術期間能夠更有效地控制出血和洩漏，有助於提高手術精度和各專業的患者預後。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球止血劑和組織密封膠：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球止血劑與組織密封膠市場：成長率分析
  • 全球止血劑與組織密封膠市場表現：規模與成長，2019-2024
  • 全球止血劑與組織密封膠市場預測：規模與成長，2024-2029 年，2034 年
  • 全球止血鉗和組織密封膠市場：總目標市場（TAM）

第6章市場區隔

  • 全球止血劑及組織密封膠市場：依產品類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 局部止血劑
  • 黏合劑和組織密封膠
  • 纖維蛋白膠
  • 其他產品類型
  • 全球止血劑和組織密封膠市場：按成分、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 基於生物學
  • 合成基底
  • 組合
  • 全球止血劑及組織密封膠市場：依通路、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 直銷
  • 經銷商
  • 網上銷售
  • 全球止血劑和組織密封膠市場：按應用、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 外科手術
  • 創傷病例
  • 心血管外科
  • 一般外科
  • 其他用途
  • 全球止血劑和組織密封膠市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 門診手術中心（ASC）
  • 專科診所
  • 研究和學術機構
  • 全球止血劑及組織密封膠市場：局部止血劑（按類型）細分，實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 機械式止血鉗
  • 活性止血劑
  • 流體止血材料
  • 複合止血鉗
  • 全球止血劑和組織密封膠市場：按黏合劑和組織密封膠（按類型）細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 合成組織黏合劑
  • 組織組織黏合劑
  • 氰基丙烯酸酯黏合劑
  • 全球止血劑和組織密封膠市場：纖維蛋白膠細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 液體纖維蛋白膠
  • 貼片型纖維蛋白膠
  • 全球止血劑和組織密封膠市場：按產品類型細分、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 明膠基止血劑
  • 膠原蛋白基止血劑
  • 氧化再生纖維素止血材料

第7章 區域和國家分析

  • 全球止血劑與組織密封膠市場：區域分析、預測及展望（2019-2024 年、2024-2029 年、2034 年）
  • 全球止血劑及組織密封膠市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 止血劑與組織密封膠市場：競爭格局
  • 止血劑和組織密封膠市場：公司簡介
    • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Meril Life Sciences Pvt. Ltd.
  • Teleflex Incorporated
  • Integra LifeSciences Holdings Corporation
  • Corza Medical Inc.
  • Artivion Inc.
  • Ethicon Inc.
  • Advanced Medical Solutions Group plc
  • Marine Polymer Technologies Inc.
  • Samyang Holdings Corporation
  • 3-D Matrix Medical Technology Co Ltd.
  • GELITA AG
  • BioCer Entwicklungs-GmbH
  • AEGIS Lifesciences Pvt. Ltd.
  • Betatech Medical Ltd.
  • Cohera Medical Inc

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029 年止血劑與組織密封膠市場：提供新機會的國家
  • 2029 年止血劑與組織密封膠市場：細分市場帶來新機會
  • 2029 年止血劑與組織密封膠市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r37010

Hemostats and tissue sealants are products utilized during surgical procedures to manage bleeding (hemostasis) and seal tissues, thereby preventing the leakage of fluids like blood or air. Hemostats function by either encouraging clot formation or physically clamping blood vessels to halt bleeding, while tissue sealants are used to close wounds or surgical cuts, supporting quicker healing and lowering the likelihood of complications.

The primary categories of hemostats and tissue sealants include topical hemostats, adhesives and tissue sealants, fibrin sealants, and others. Topical hemostats are substances or materials directly applied to bleeding areas to control bleeding during surgeries or traumatic injuries. These are formulated from biological-based, synthetic-based, or combined materials, and are distributed through various channels such as direct sales, distributors, and online platforms. Their applications span across surgical procedures, trauma care, cardiovascular and general surgeries, among others, and they serve multiple end users including hospitals, ambulatory surgical centers (ASCs), specialty clinics, and academic and research institutions.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The hemostats and tissue sealants market research report is one of a series of new reports from The Business Research Company that provides hemostats and tissue sealants market statistics, including hemostats and tissue sealants industry global market size, regional shares, competitors with a hemostats and tissue sealants market share, hemostats and tissue sealants market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats and tissue sealants industry. This hemostats and tissue sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostats and tissue sealants market size has grown strongly in recent years. It will grow from $4.07 billion in 2024 to $4.35 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth during the historic period can be credited to an expanding elderly population, a higher occurrence of trauma and accidents, a growing prevalence of cardiovascular diseases, increased investments in the medical field, and a rising preference for minimally invasive surgical procedures.

The hemostats and tissue sealants market size is expected to see strong growth in the next few years. It will grow to $5.61 billion in 2029 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth in the forecast period can be attributed to the increasing use of hemostats in ambulatory surgical centers, rising demand for biocompatible and synthetic sealants, greater investments in surgical innovation and research and development, heightened awareness of blood management during surgeries, and growing healthcare spending. Key trends expected during this period include progress in synthetic polymer technologies, innovation in drug-delivery-based sealants, incorporation of hemostatic agents into minimally invasive procedures, advancements in dual-function sealants and hemostats, and the development of bioengineered and biocompatible materials.

The growing number of surgical procedures is expected to drive the expansion of the hemostats and tissue sealants market. Surgical procedures involve manual and instrumental techniques performed by surgeons to diagnose, treat, or remove diseased tissues or organs, or to restore bodily functions. The increase in these procedures is largely attributed to the rising prevalence of chronic diseases, which frequently require surgical intervention for proper management, treatment, or to prevent complications. Hemostats and tissue sealants play a crucial role in these procedures by effectively controlling bleeding and sealing tissues, thereby minimizing complications and enhancing surgical outcomes. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a U.S.-based professional organization for board-certified aesthetic plastic surgeons, reported a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures conducted worldwide. This trend underscores how the increasing number of surgical procedures is fueling the demand for hemostats and tissue sealants.

Leading companies in the hemostats and tissue sealants market are prioritizing the development of innovative products, such as ready-to-use absorbable collagen pads, to enhance the effectiveness and efficiency of surgical care. These collagen-based hemostats are designed using bioactive, resorbable materials that require no preparation, offering immediate application for effective tissue sealing and hemostasis. In April 2025, Baxter International Inc., a U.S.-based healthcare company, introduced the Hemopatch Sealing Hemostat at a symposium in Austria. This new product is designed for room temperature storage and offers the convenience of being ready-to-use without the need for pre-warming. It is suitable for both open and minimally invasive surgeries and eliminates the need for refrigeration or additional preparation. The Hemopatch's strong adhesive capabilities, extended shelf life, and rapid hemostatic response enable more efficient bleeding and leakage control during surgery, contributing to improved surgical precision and better patient recovery outcomes across various specialties.

In March 2024, Advanced Medical Solutions Group PLC, a UK-based medical technology company, acquired Peters Surgical SAS for $154.6 million. This acquisition is aimed at expanding Advanced Medical Solutions' surgical product portfolio, reinforcing its footprint in key European markets, and enhancing its position in the global wound care and closure technologies sector. Peters Surgical SAS, based in France, specializes in producing medical devices and instruments focused on hemostats and tissue sealants.

Major players in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton, Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., and Cohera Medical Inc.

North America was the largest region in the hemostats and tissue sealants market in 2024. The regions covered in hemostats and tissue sealants report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hemostats and tissue sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hemostats and tissue sealants market consists of sales of gelatin-based hemostats, fibrin sealants, oxidized regenerated cellulose, thrombin-based hemostats, and cyanoacrylate-based tissue adhesives. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostats And Tissue Sealants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostats and tissue sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostats and tissue sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemostats and tissue sealants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Topical Hemostats; Adhesives And Tissue Sealants; Fibrin Sealants; Other Product Types
  • 2) By Composition: Biological Based; Synthetic Based; Combination
  • 3) By Distribution Channel: Direct Sales; Distributors; Online Sales
  • 4) By Application: Surgical Procedures; Trauma Cases; Cardiovascular Surgery; General Surgery; Other Applications
  • 5) By End-Users: Hospitals; Ambulatory Surgical Centers (ASCs); Specialized Clinics; Research And Academic Institutes
  • Subsegments:
  • 1) By Topical Hemostats: Mechanical Hemostats; Active Hemostats; Flowable Hemostats; Combination Hemostats
  • 2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives; Biological Tissue Adhesives; Cyanoacrylate-Based Adhesives
  • 3) By Fibrin Sealants: Liquid Fibrin Sealants; Patch-Based Fibrin Sealants
  • 4) By Other Product Types: Gelatin-Based Hemostats; Collagen-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats
  • Companies Mentioned: Johnson & Johnson; Medtronic plc; Becton, Dickinson and Company (BD); Stryker Corporation; Baxter International Inc.; Meril Life Sciences Pvt. Ltd.; Teleflex Incorporated; Integra LifeSciences Holdings Corporation; Corza Medical Inc.; Artivion Inc.; Ethicon Inc.; Advanced Medical Solutions Group plc; Marine Polymer Technologies Inc.; Samyang Holdings Corporation; 3-D Matrix Medical Technology Co Ltd.; GELITA AG; BioCer Entwicklungs-GmbH; AEGIS Lifesciences Pvt. Ltd.; Betatech Medical Ltd.; Cohera Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemostats And Tissue Sealants Market Characteristics

3. Hemostats And Tissue Sealants Market Trends And Strategies

4. Hemostats And Tissue Sealants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hemostats And Tissue Sealants Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hemostats And Tissue Sealants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hemostats And Tissue Sealants Market Growth Rate Analysis
  • 5.4. Global Hemostats And Tissue Sealants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hemostats And Tissue Sealants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hemostats And Tissue Sealants Total Addressable Market (TAM)

6. Hemostats And Tissue Sealants Market Segmentation

  • 6.1. Global Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Topical Hemostats
  • Adhesives And Tissue Sealants
  • Fibrin Sealants
  • Other Product Types
  • 6.2. Global Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biological Based
  • Synthetic Based
  • Combination
  • 6.3. Global Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Direct Sales
  • Distributors
  • Online Sales
  • 6.4. Global Hemostats And Tissue Sealants Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Surgical Procedures
  • Trauma Cases
  • Cardiovascular Surgery
  • General Surgery
  • Other Applications
  • 6.5. Global Hemostats And Tissue Sealants Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialized Clinics
  • Research And Academic Institutes
  • 6.6. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Topical Hemostats, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mechanical Hemostats
  • Active Hemostats
  • Flowable Hemostats
  • Combination Hemostats
  • 6.7. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Adhesives And Tissue Sealants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Synthetic Tissue Adhesives
  • Biological Tissue Adhesives
  • Cyanoacrylate-Based Adhesives
  • 6.8. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Fibrin Sealants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Liquid Fibrin Sealants
  • Patch-Based Fibrin Sealants
  • 6.9. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Gelatin-Based Hemostats
  • Collagen-Based Hemostats
  • Oxidized Regenerated Cellulose-Based Hemostats

7. Hemostats And Tissue Sealants Market Regional And Country Analysis

  • 7.1. Global Hemostats And Tissue Sealants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hemostats And Tissue Sealants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemostats And Tissue Sealants Market

  • 8.1. Asia-Pacific Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemostats And Tissue Sealants Market

  • 9.1. China Hemostats And Tissue Sealants Market Overview
  • 9.2. China Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemostats And Tissue Sealants Market

  • 10.1. India Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemostats And Tissue Sealants Market

  • 11.1. Japan Hemostats And Tissue Sealants Market Overview
  • 11.2. Japan Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemostats And Tissue Sealants Market

  • 12.1. Australia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemostats And Tissue Sealants Market

  • 13.1. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemostats And Tissue Sealants Market

  • 14.1. South Korea Hemostats And Tissue Sealants Market Overview
  • 14.2. South Korea Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemostats And Tissue Sealants Market

  • 15.1. Western Europe Hemostats And Tissue Sealants Market Overview
  • 15.2. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemostats And Tissue Sealants Market

  • 16.1. UK Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemostats And Tissue Sealants Market

  • 17.1. Germany Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemostats And Tissue Sealants Market

  • 18.1. France Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemostats And Tissue Sealants Market

  • 19.1. Italy Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemostats And Tissue Sealants Market

  • 20.1. Spain Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemostats And Tissue Sealants Market

  • 21.1. Eastern Europe Hemostats And Tissue Sealants Market Overview
  • 21.2. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemostats And Tissue Sealants Market

  • 22.1. Russia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemostats And Tissue Sealants Market

  • 23.1. North America Hemostats And Tissue Sealants Market Overview
  • 23.2. North America Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemostats And Tissue Sealants Market

  • 24.1. USA Hemostats And Tissue Sealants Market Overview
  • 24.2. USA Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemostats And Tissue Sealants Market

  • 25.1. Canada Hemostats And Tissue Sealants Market Overview
  • 25.2. Canada Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemostats And Tissue Sealants Market

  • 26.1. South America Hemostats And Tissue Sealants Market Overview
  • 26.2. South America Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemostats And Tissue Sealants Market

  • 27.1. Brazil Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemostats And Tissue Sealants Market

  • 28.1. Middle East Hemostats And Tissue Sealants Market Overview
  • 28.2. Middle East Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemostats And Tissue Sealants Market

  • 29.1. Africa Hemostats And Tissue Sealants Market Overview
  • 29.2. Africa Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemostats And Tissue Sealants Market Competitive Landscape And Company Profiles

  • 30.1. Hemostats And Tissue Sealants Market Competitive Landscape
  • 30.2. Hemostats And Tissue Sealants Market Company Profiles
    • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hemostats And Tissue Sealants Market Other Major And Innovative Companies

  • 31.1. Meril Life Sciences Pvt. Ltd.
  • 31.2. Teleflex Incorporated
  • 31.3. Integra LifeSciences Holdings Corporation
  • 31.4. Corza Medical Inc.
  • 31.5. Artivion Inc.
  • 31.6. Ethicon Inc.
  • 31.7. Advanced Medical Solutions Group plc
  • 31.8. Marine Polymer Technologies Inc.
  • 31.9. Samyang Holdings Corporation
  • 31.10. 3-D Matrix Medical Technology Co Ltd.
  • 31.11. GELITA AG
  • 31.12. BioCer Entwicklungs-GmbH
  • 31.13. AEGIS Lifesciences Pvt. Ltd.
  • 31.14. Betatech Medical Ltd.
  • 31.15. Cohera Medical Inc

32. Global Hemostats And Tissue Sealants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemostats And Tissue Sealants Market

34. Recent Developments In The Hemostats And Tissue Sealants Market

35. Hemostats And Tissue Sealants Market High Potential Countries, Segments and Strategies

  • 35.1 Hemostats And Tissue Sealants Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hemostats And Tissue Sealants Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hemostats And Tissue Sealants Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer